KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Non-Current Liabilities (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Total Non-Current Liabilities for 11 consecutive years, with $1.4 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Non-Current Liabilities rose 19.88% year-over-year to $1.4 billion, compared with a TTM value of $1.4 billion through Sep 2025, up 19.88%, and an annual FY2024 reading of $1.2 billion, up 15.23% over the prior year.
  • Total Non-Current Liabilities was $1.4 billion for Q3 2025 at Medpace Holdings, up from $1.3 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.4 billion in Q3 2025 and bottomed at $576.3 million in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $993.8 million, with a median of $1.0 billion recorded in 2022.
  • The sharpest move saw Total Non-Current Liabilities soared 68.68% in 2022, then dropped 2.17% in 2023.
  • Year by year, Total Non-Current Liabilities stood at $689.3 million in 2021, then surged by 36.87% to $943.4 million in 2022, then grew by 13.38% to $1.1 billion in 2023, then increased by 15.23% to $1.2 billion in 2024, then grew by 13.98% to $1.4 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for MEDP at $1.4 billion in Q3 2025, $1.3 billion in Q2 2025, and $1.3 billion in Q1 2025.